THE CEO OF SINTETICA
IS A WINNER AT THE EUROPEAN CEO AWARDS 2018
A prestigious new addition to the list of awards won by Sintetica SA, the oldest pharmaceutical company in the Canton of Ticino, specialising in the production of top quality medicines for locoregional anaesthesiology and pain management. The firm's CEO, Augusto Mitidieri, received the European CEO Award 2018* for "Best CEO in the Pain Management Industry".
The European CEO Awards 2018 recognise the leaders who have an eye for innovation and, having firmly positioned their companies at the front of the pack, are now shaping the industries they
Justification for this award includes the words:
"Mitidieri has shown a commitment to maintaining the firm's leading
position within the global pharmaceuticals and pain management
One of Mitidieri's main ambitions has been to implement an organisational model based on responsibility and meritocracy, rather than rigid internal hierarchies. Such an ideal falls in line with Sintetica's aim to create a working environment based on innovative ideas and positive dynamics, resulting in first-rate products that help hundreds of thousands of patients worldwide.
Most recently, Sintetica obtained marketing authorisation in the USA for its product Clorotekal, making it one of very few SMEs in the world to have registered an original pharmaceutical product in the country.
You can find an extended article from page 56 in the virtual edition
of the issue here: https://www.europeanceo.com/magazine/
* European CEO is a leading subscription-based print and online publication, delivered quarterly to c-suite executives in 28 countries throughout Europe. With a network of journalists reporting to headquarters in London, European CEO provides the numbers, detailed analysis, strategy and guidance needed to make qualified business decisions in Europe's diverse marketplace.
Proving the Excellence of Sintetica.
Sintetica is recognised at this years Le Fonti Awards.
Many world-class forces of the economy gathered over an evening event
and witnessed Augusto Mitidieri being awarded for the second consecutive
year the prestigious award of CEO of the Year for Corporate Social
For being an international force of excellence in the pharmaceutical sector,
with particular reference to the treatment of pain. Thanks to its CEO's
charisma and highly professional team, Sintetica has proven itself to be one
of the fastest growing realities in the market and perfectly satisfies the CSR
[Le Fonti Awards]
The motivation of this acknowledgement comes from the material
representation of the spirit, envisioned by Augusto Mitidieri and embodied
by the entire company, with which Sintetica manages its impressive
expansion on the global market, strengthened by products of the highest
quality and efficiency.
The award of CEO of the Year for Corporate Social Responsibility is further
acknowledgement of the excellent work Sintetica does as a whole.
Sintetica SA Named Europe's Pharmaceutical Company of the Year by Business Worldwide Magazine.
Swiss based pharmaceutical company Sintetica SA has another award to add to its already impressive collection, having been named 'Pharmaceutical Company of the Year - Europe' in the 2018 Brand of the Year Awards by Business Worldwide Magazine.
The 2018 Brand of the Year Awards recognize and reward organizations that have performed exceptionally over the previous 12 months, becoming dynamic forces within their industries. The judging panel look not only for businesses of world class quality, but those that strive to push boundaries, challenge perceptions and respond to global problems; earning respect from their peers and becoming employers of choice. Sintetica SA impressed the panel with its clear commitment to ongoing development, innovation and "quality without compromise" - the company's mantra.
Sintetica SA's CEO Augusto Mitidieri is leading the way in a new business model that encourages collaborative and horizontal working, combining state of the art technology with a human-centred approach. The company has come a long way since it was formed almost 100 years ago, going from a small business in Switzerland to a global company employing 300 people across 29 countries. Delivering injectable anaesthetics and analgesics to patients worldwide, the company has been the market leader in its field for many years and is now forging the way in the growing field of neuromodulation. The global division was only established in 2012, but growth is already exceeding 200% - a testament to the hard work and commitment of the CEO and his team.
Mitidieri says that the company's culture of respect has played an important role in its success. "What differentiates us from competitors is that all strategic choices are based on values of respect, a core value that permeates across every employee. It is about creating a pleasant environment in which employees can work and express themselves. When hiring new employees, we look for 'smart' people who share our thirst for diversity, our respect for traditions and our aim to be a leading global company."
This "people first" approach extends way beyond the staff team, positively affecting relationships with business partners and realizing the best possible care solutions for patients. Mitidieri's innovative new organization model, the 'Human Centered Organization', is based on the idea of responsibility and meritocracy rather than hierarchy, with managers moving from a role of command to a coaching style.
This refreshing approach certainly appears to be working. The company has recently obtained the go-ahead to market a new drug application in the United States; an outstanding achievement as one of the few small-medium sized companies in the world to register a new product in the US. It is also developing a radical new innovation in the field of post-surgery pain relief that has the potential to change the way pain is managed throughout the world.
M&A Today Global Awards 2018
M&A Today Global Award for Excellence in Drug Development & Best for Clinic Trials 2018 - Europe
Worldwide Business Review - 2018
Sintetica S.A. - Award for Excellence in Anaesthetics & Analgesic - Switzerland Small Business Elite 2018
ACQ Gamechangers™ Healthcare Awards 2018.
Pasquale Mitidieri, Global markets Corporate Director, tells us more about Global Division's growth.
CPhI Pharma Awards - 2018
Finalist - CPhI 2018 Madrid, Spain.
The prestigious Le Fonti Awards reward Sintetica’s CEO.
This is decidedly a golden period for Sintetica SA, the pharmaceutical company from Canton Ticino specialized in products for pain therapy (www.sintetica.com). The CEO Augusto Mitidieri received a prestigious award in the internationalization category for the year 2017 from the Fonti Awards (www.lefontiawards.it
The statement regarding Mitidieri's award is
"For his capacity to lead with foresight and attention to human resources in the context of an international specialization in injectable products for pain relief and therapy. In particular, for having invested in the education vand continuous training of the employees in terms of the global standards for Corporate social responsibility and foreign development."the sentence was translated from Italian by Sintetica
The "Le Fonti" Awards are incorporated in the IAIR system of international awards, an event of great prominence for the business community. It reunites corporate leaders, legal offices and individuals from the highest tiers of the financial world.
This new award refines the already impressive recent prizes bestowed upon Sintetica SA as Pharmaceutical Company of the year 2016 Switzerland and upon Augusto Mitidieri as European CEO of the year 2016.
Business Worldwide’s CEO Awards 2017
Augusto Mitidieri of Sintetica is European Pharmaceutical CEO Champion.
CEO of Sintetica SA Augusto Mitidieri is a worthy
recipient of the Business Worldwide Magazine
award Best CEO/Pharmaceutical Industry Europe
Ultimately in charge of 230 employees spread
across 25 different countries, his job is incredibly
strategic, thanks to competition from emerging
countries and long-term austerity measures
Europe-wide. But it's not all doom and gloom for
this talented CEO. That's because today there is
more investment in pharmaceutical research and
development than ever before.
And Mitidieri is determined that Sintetica - whom
he has worked with for the past 17years – will
remain a leading player within the industry. The
95-year-old company develops injectable
anaesthetics and analgesics on a global scale.
These are specifically used for local anaesthesia,
pain management and neuromodulation. Mitidieri
regards development, production and marketing
as crucial areas for the company's future strategy.
Receiving his Best CEO Award from the magazine's
executives, Mitidieri insisted that innovation within
his industry wasn't merely about products, but also
management style and organisation.
"Getting this right has been one of
the key elements of our success here
at Sintetica" he declared.
Sintetica has its HQ in Switzerland, where it
employs around 40 per cent of the company's
total workforce. Other countries in which it has a
base includes Germany, Austria, Italy and the
In order for sintetica to retain its global leadership
peg Mitidieri believes strategic partnering and
business development are the keys to long-term
"Our specialist sales teams in Switzerland,
Germany, Austria, the UK and Ireland directly
promote and market our products, while our
Global Division delivers our top medicines through
a network of strategic international worldwide
partners" ex-lained Mitidieri, who is a graduate in
Management Engineering from the Politecnico di
He is hardly apologetic in admitting his 'pickiness'
when it comes to choosing business partners. They
must share the values of Sintetica, particularly its
way of prioritising people and relationships over
"All our partners must meet strict
ethical criteria and share our
innovation-driven quality without
compromising our value
proposition" said Mitidieri.
As you would expect, Sintetica is a company which
regards staff as a core resource. As such Mitidieri
strives to offer a creative culture and doesn't even
mind risk taking too much, provided it's what he
would describe as "informed".
"Making Sintetica a great
place to work is our belief and is, in
fact, part of our DNA."
European Enterprise Awards - 2017
Sintetica SA - Best Pharmaceutical Company 2017 - Switzerland.
CPhI Pharma Awards - 2017
Finalist - CPhI 2017 Messe Frankfurt,
ACQ5 Awards - Growth Company of the year 2017.
Can respect be the key to global growth in the pharmaceutical industry?
Worldwide Business Review - 2017
Winner of the awards Excellence in
HR - Managing Director & Vp, Human
Resource of the year 2017.
CV Magazine Awards - 2017
Sintetica, man at the centre
The palmarès of Sintetica SA Mendrisio, the oldest pharmaceutical
company in the Canton Ticino, has been recently enriched with new
important international awards.
Such acknowledgments are actually marking the pace of the
Corporate’s signicant growth, which is also active in the international
CV magazine has awarded once again Sintetica for the year 2017, in
the small business section, as the best European pharmaceutical
company. At the same time, Mr. Augusto Mitidieri, Sintetica’s CEO,
earned the title of the best pharmaceutical CEO in the world.
The main reason behind the attribution of the two prizes lies in the
total respect as core value of Sintetica, recognized as a distinctive
strategic factor in the entire pharma panorama. Likewise, in order to
assure absolute excellence, Mr. Mitidieri, CEO, is now committed to
building a "human-centric" corporate culture.
CV Magazine - Small Business Awards 2016
Sintetica® Pharmaceutical Company of the year 2016 Switzerland.
European CEO of the year 2016
European CEO of the year 2016 Augusto Mitidieri - Sintetica.